BlackRock, Inc. 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
BLACKROCK INC BLK |
9,940,846 6.700% |
-1,480,708 (-12.96%) |
Filing |
| 2024-01-26 11:49 am Sale |
2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
BLACKROCK INC BLK |
11,421,554 7.900% |
-952,643 (-7.70%) |
Filing |
| 2023-02-13 3:52 pm Purchase |
2022-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
BLACKROCK INC BLK |
12,374,197 8.700% |
12,374,197 (New Position) |
Filing |